Table 2.
Response rate f (%)(MD=4) | Remission rate f (%)(MD=4) | Outcome due to placebo effects f (%) (MD=3) | |
---|---|---|---|
Mdn | 54% | 33% | 26% |
0–10% | 0 (0.0) | 0 (0.0) | 6 (7.9) |
11–20% | 0 (0.0) | 11 (13.9) | 9 (11.8) |
21–30% | 5 (6.7) | 13 (16.5) | 23 (30.3) |
31–40% | 5 (6.7) | 19 (25.3) | 19 (25.0) |
41–50% | 10 (13.3) | 8 (10.7) | 11 (14.5) |
51–60% | 21 (28.0) | 9 (12.0) | 5 (6.6) |
61–70% | 18 (22.8) | 9 (12.0) | 3 (3.9) |
71–80% | 13 (16.5) | 4 (5.3) | 0 (0.0) |
81–90% | 2 (2.5) | 2 (2.7) | 0 (0.0) |
91–100% | 1 (1.3) | 0 (0.0) | 0 (0.0) |